Non-viral vasculogenic reprogramming restores cognition and mitigates pathology in Alzheimer's disease
Diego Alzate‐Correa, Jonathan P. Stranan, Maria Angelica Rincon‐Benavides, Natalia Areiza Mazo, Luis Fernando Narváez-Pérez, Shara Jaramillo-Garrido, Tracy Nguyen, Roma Patel, William R. Lawrence, Ludmila Diaz‐Starokozheva, Ana I. Salazar‐Puerta, Andrea Tran, Alex Valentine, Natalia Claire Mendonca, Olivia Seline, , Daniel F. Gallego-Perez
This study shows that non-viral reprogramming of fibroblasts to vasculogenic cells improves cognition and reduces pathology in Alzheimer's disease mouse models.
bioRxiv · Jan 24, 2026 · PreprintNeuroscience